Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural LifeBON -1.75%42 EV-to-EBITDA is -317.02 as of Jul. 30, 2026. GuruFocus rates BON with a GF Score™ of 42/100 and a GF Value™ of $0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,320 Chemicals companies, Bon Natural Life ranks worse than 75757.5% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bon Natural Life's enterprise value is $18.07 Mil.
Bon Natural Life's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.06 Mil. Therefore, Bon Natural Life's EV-to-EBITDA for today is -317.02.
The historical rank and industry rank for Bon Natural Life's EV-to-EBITDA or its related term are showing as below:
BON'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -322.18 Med: 1.93 Max: 31.44
Current: -317.02
During the past 8 years, the highest EV-to-EBITDA of Bon Natural Life was 31.44. The lowest was -322.18. And the median was 1.93.
BON's EV-to-EBITDA is ranked worse than 100% of 1320
companies
in the Chemicals industry
Industry Median: 13.23
vs BON: -317.02
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Bon Natural Life (NAS:BON) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bon Natural Life's PE Ratio (TTM) for today is calculated as:
Bon Natural Life's share price for today is $1.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bon Natural Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $12.234.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Bon Natural Life's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Bon Natural Life's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's EV-to-EBITDA falls into.
Bon Natural Life's current Enterprise Value is $18.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bon Natural Life's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a EV-to-EBITDA of -317.02 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bon Natural Life. According to the industry distribution chart, Bon Natural Life ranks #999999 out of 1320 companies in the Chemicals industry.
Is Bon Natural Life's EV-to-EBITDA too high?
Bon Natural Life's current EV-to-EBITDA is -317.02. Based on the distribution chart, Bon Natural Life ranks #999999 out of 1320 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's EV-to-EBITDA compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #999999 out of 1320 companies for EV-to-EBITDA. This places Bon Natural Life in the lower half of its industry. The industry median EV-to-EBITDA is 13.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 13.23, based on 1,320 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bon Natural Life. For the Chemicals industry, the median EV-to-EBITDA is 13.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bon Natural Life's current EV-to-EBITDA is -317.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.12 — trading 47.4% above its estimated fair value. The current EV-to-EBITDA is -317.02. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bon Natural Life (BON), the current EV-to-EBITDA is -317.02 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.12 is trading 47.4% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
EV-to-EBITDA: -317.02
GF Value™: $0.76 vs. price of $1.12 (47.4% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
